All articles by

URGO Medical strengthens its position in North America by acquiring Realm Therapeutics’ assets

This acquisition reinforces URGO Medical’s innovative product portfolio and its footprint in North America. URGO Medical acquires a worldwide proprietary…

Innoblative Designs gets FDA approval for SIRA RFA electrosurgical device

SIRA RFA electrosurgical device is a novel radiofrequency ablation (RFA) applicator, which provides energy for use in electrosurgery. The next-generation…

Signum Surgical secures €3.6m in grant funding to support launch of therapy for patients with common colorectal disease

The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies…

Spry Health gets FDA approval for Loop system to monitor COPD patients

Loop is said to be the first clinical-grade wearable device that enables clinicians to remotely monitor their patients with chronic…

Eye care firm Alcon launches as independent firm

With operations in around 74 countries, Alcon is a global eye care device firm with complementary businesses in surgical and…

Zebra Medical Vision adds third patent to bone health portfolio

Zebra-Med’s patents address statistical and machine learning methods to assess the risk, as well as the existence of osteoporotic fractures,…

Canon Medical introduces new Aplio ultrasound product platform

Aplio a-series, which includes a550 and a450, has been developed for use in various clinical areas ranging from cardiology to…

InBody USA innovates blood pressure measurement

The global medical tech company is well-renowned for innovative devices like the award-winning InBody 570 Body Composition Analyzer. “InBody established…

Enlitic closes series B funding to advance artificial intelligence solutions for radiologists

The investment was led by Marubeni, with whom the company has been developing the Japanese market since 2017. The round…

TherOx gets FDA approval for SSO2 Therapy to treat heart attack

Claimed to be the first and only FDA-approved treatment beyond percutaneous coronary intervention (PCI), the SSO2 Therapy will allow interventional…